Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • UK
  • Africa
  • Afrique
  • CH

Browsing Tag

T-cell engagers

3 posts
RRoche
Roche nabs Simcere’s preclinical trispecific TCE in $1.53B deal
Read More

Roche nabs Simcere’s preclinical trispecific TCE in $1.53B deal

  • 2026-09-06
To read the full article sign up for free or sign in. Sep. 2, 2026 By Marian (YoonJee)…
RRoche
Calidi Biotherapeutics Gets FDA Feedback on CLD-401
Read More

Calidi Biotherapeutics Gets FDA Feedback on CLD-401

  • 2026-07-24
Calidi Biotherapeutics (NYSE American: CLDI) issued a mid-year 2026 update highlighting regulatory, pipeline, governance, and…
NNovartis
Novartis stands by $5B Pluvicto goal despite EU regulatory setback
Read More

Novartis stands by $5B Pluvicto goal despite EU regulatory setback

  • 2026-06-18
Novartis CEO Vas Narasimhan is doubling down on his $5 billion peak sales projection for Pluvicto, even as…
Switzerland
www.europesays.com